US 10899732
Substituted benzamides useful as sodium channel blockers
granted A61KA61K31/416A61P
Quick answer
US patent 10899732 (Substituted benzamides useful as sodium channel blockers) held by Xenon Pharmaceuticals Inc. expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/416, A61P, A61P11/00, A61P17/04